Clinical Trial Update: Vaccination of AJCC Stage IIB, IIC, III and IV Melanoma Patients With Human and Mouse Tyrosinase DNA Vaccines [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating human and mouse tyrosinase DNA vaccines in melanoma patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Human tyrosinase DNA vaccine (tyrosinase DNA vaccine)
• Mouse tyrosinase DNA vaccine (tyrosinase DNA vaccine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Melanoma, Skin | Phase 1 | Status: COMPLETED